Company NeuBase Therapeutics, Inc. Nasdaq
Equities
NBSE
US64132K2015
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | -3.20% | 0.00% | -48.93% |
Business Summary
Number of employees: 37
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,751,590 | 3,249,699 ( 86.62 %) | 0 | 86.62 % |
Company contact information
NeuBase Therapeutics, Inc.
350 Technology Drive Suite 421
15219, Pittsburgh
+
http://www.neubasetherapeutics.comSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.43% | 54.04B | |
+43.57% | 41.96B | |
-1.27% | 41.92B | |
-7.59% | 28.35B | |
+12.10% | 26.35B | |
-22.35% | 19B | |
+7.76% | 13B | |
+28.93% | 12.28B | |
+24.94% | 12.19B |
- Stock Market
- Equities
- O7P Stock
- NBSE Stock
- Company NeuBase Therapeutics, Inc.